Our study showed that microtubule-depolymerizing agent BPR0L075 is also capable of inducing Bcl-XL phosphorylation in parental ovarian cancer cells, but not in the paclitaxel-resistant cells, where mitotic catastrophe is the dominant mode of cell death. This evidence concerns the gene BCL2L1 and ovarian cancer.